These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 6443491)

  • 1. [Gingival hyperplasia and diphenylhydantoin].
    Barone GP; Arata E; Salmeri S; Patrone M
    Parodontol Stomatol (Nuova); 1984; 23(3 Suppl 3):149-55. PubMed ID: 6443491
    [No Abstract]   [Full Text] [Related]  

  • 2. Levels of 5,5-diphenylhydantoin and its major metabolite in human serum, saliva, and hyperplastic gingiva.
    Conard GJ; Jeffay H; Boshes L; Steinberg AD
    J Dent Res; 1974; 53(6):1323-9. PubMed ID: 4529919
    [No Abstract]   [Full Text] [Related]  

  • 3. Gingival hyperplasia and diphenylhydantoin.
    Ciancio SG; Yaffe SJ; Catz CC
    J Periodontol; 1972 Jul; 43(7):411-4. PubMed ID: 4504524
    [No Abstract]   [Full Text] [Related]  

  • 4. Dilantin (diphenylhydantoin): its effects on the gingival tissue.
    Bergmann CL
    Dent Dig; 1967 Feb; 73(2):63-70. PubMed ID: 5225921
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gingival hyperplasia in epileptic patients treated with diphenylhydantoin. Study by light and electron microscopy].
    Tsutsumi V; Hara Ortíz F; Alvarez Fuertes G
    Rev Invest Salud Publica; 1973; 33(3-4):1-16. PubMed ID: 4791088
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of 5,5-diphenylhydantoin on a gingival hyperplasia development.
    Drízhal I; Spacek J; Hrdinová V; Lichý J; Kaut V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):625-89. PubMed ID: 6972082
    [No Abstract]   [Full Text] [Related]  

  • 7. Diphenylhydantoin gingival hyperplasia in Macaca arctoides: a new human model.
    Staple PH; Reed MJ; Mashimo PA
    J Periodontol; 1977 Jun; 48(6):325-36. PubMed ID: 405470
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tooth health, drugs, and gingival hyperplasia].
    Munthe-Kaas A; Storhaug K
    Tidsskr Nor Laegeforen; 1978 Jan; 98(3):161-2. PubMed ID: 628914
    [No Abstract]   [Full Text] [Related]  

  • 9. Diphenylhydantoin gingival hyperplasia: incidence and etiology.
    Zeitler DL; Zach GA
    J Hosp Dent Pract; 1980; 14(1):41-4. PubMed ID: 6964964
    [No Abstract]   [Full Text] [Related]  

  • 10. [Application of drug monitoring with saliva--the influence of phenytoin upon the salivary inorganic constituents].
    Watanabe S; Igarashi S; Ichida T
    Rinsho Byori; 1986 Mar; 34(3):254-61. PubMed ID: 3712786
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of diphenylhydantoin gingival hyperplasia among Egyptian children.
    Soliman NA; el-Ashiry GM; el-Gally KA; Attia MA
    Egypt Dent J; 1978 Jan; 24(1):11-22. PubMed ID: 292569
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of phenytoin associated gingival enlargement--a 15-month longitudinal study.
    Pihlstrom BL; Carlson JF; Smith QT; Bastien SA; Keenan KM
    J Periodontol; 1980 Jun; 51(6):311-7. PubMed ID: 6930469
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gingival hyperplasia due to diphenylhydantoin, cyclosporin A and nifedipine. A histopathological comparison].
    Silvestri E; Veraldi S; Piferi M; Sala F; Bencini L; Marini D
    Minerva Stomatol; 1988 Mar; 37(3):189-92. PubMed ID: 3166093
    [No Abstract]   [Full Text] [Related]  

  • 14. Diphenylhydantoin-induced gingival overgrowth in man: a clinico-pathological study.
    Peñarrocha-Diago M; Bagán-Sebastián JV; Vera-Sempere F
    J Periodontol; 1990 Sep; 61(9):571-4. PubMed ID: 2213467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gingival hyperplasia resulting from diphenylhydantoin in children and adults.
    Matsumoto K; Nakagawa K; Kaneko Z
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):369-71. PubMed ID: 1176242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinicopathological review. Diphenylhydantoin gingival hyperplasia: 2. Aetiology, pathogenesis, differential diagnosis and treatment.
    Angelopoulos AP
    Dent J; 1975 May; 41(5):275-7, 283. PubMed ID: 1055114
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenytoin-induced gingival overgrowth control in severely retarded children.
    Steinberg SC; Steinberg AD
    J Periodontol; 1982 Jul; 53(7):429-33. PubMed ID: 6956708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dilantin gingival hyperplasia: patient evaluation in relation to anticonvulsant dosage, degree of oral hygiene and extension of lesion].
    Pugliesi NS; da Silva FT; Saleh ER; Biagini VS; Marin de los Rios C; Rode Sde M
    Rev Faculdade Odontol FZL; 1989; 1(2):97-103. PubMed ID: 2485648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epileptic therapy and gingival considerations.
    Mégarbané JM
    Rev Dent Liban; 1974 Jun; 24(2):29-34. PubMed ID: 4608029
    [No Abstract]   [Full Text] [Related]  

  • 20. [Transport of immunoglobulins in the gingival epithelium. I. In diphenylhydantoin-induced hyperplasia].
    Perona M; Ibáñez P; Sagredo E; Pino A; Riera P; Tabernero M; Urcelay B; Ortiz G
    Av Odontoestomatol; 1985; 1(6):314-8, 321-3. PubMed ID: 3915870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.